Safety, Tolerability, and Pharmacokinetics of a Long-Acting Broadly Neutralizing Human Immunodeficiency Virus Type 1 (HIV-1) Monoclonal Antibody VRC01LS in HIV-1–Exposed Newborn Infants is a research paper published in The Journal of Infectious Diseases (2021). On theSindex it has a DataRank of 0.598. It has been cited 53 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.598
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NIH
Grant: UM1AI068632
NIH
Grant: UM1AI068616
NIH
Grant: UM1AI106716
NIH
Grant: HHSN275201800001I
Duke University Center for AIDS Research
Grant: 5P30 AI064518
National Center for Advancing Translational Sciences
Grant: UL1 TR001082
NICHD NIH HHS
Grant: HHSN275201800001C
NIAID NIH HHS
Grant: P30 AI064518
NIAID NIH HHS
Grant: U01 AI069436
NIAID NIH HHS
Grant: UM1 AI069436
National Institute of Allergy and Infectious Diseases
National Institute of Mental Health
Eunice Kennedy Shriver National Institute of Child Health and Human Development
International Maternal Pediatric Adolescent AIDS Clinical Trials Network
Colorado Clinical and Translational Science Award
MeSH Terms
Keywords